2020
DOI: 10.1097/md.0000000000022574
|View full text |Cite
|
Sign up to set email alerts
|

Extralobar pulmonary sequestration with elevated serum neuron-specific enolase

Abstract: Rationale: Pulmonary sequestration (PS) presenting with elevated serum tumor markers is rare, and it might be misdiagnosed as malignancy. Patient concerns: A 26-year-old asymptomatic male patient was admitted because the x-ray showed an intrathoracic lesion. Meanwhile, the serum neuron-specific enolase (NSE) was elevated. Three-dimensional computed tomography angiography revealed an isolated feeding vessel arising from the aorta. Diagnoses: E… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…It is a specific marker for neurons and peripheral neuroendocrine cells and so the most reliable tumor marker in the diagnosis, prognosis, and post-treatment of small-cell lung cancer. NSE being a human brain protein is present in about 0.4–2.2% (>5 ng mL –1 ) of total soluble protein of the brain, and excessive increase in such levels indicates a metastatic disease such as melanoma, seminoma, renal cell carcinoma, carcinoid tumors, Guillain-Barre syndrome, Creutzfeldt-Jakob disease, and so on. , The amount of NSE present in the brain predicts quantifiable measures of brain damage, which lead to strokes, hemorrhage, seizures, etc . Recently, reports have published sufficient data of COVID-19 positive patients showing the elevated level of NSE, signifying the role of NSE as a potential clinical biomarker for COVID-19 because it primarily targets human respiratory and neurological systems. , …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is a specific marker for neurons and peripheral neuroendocrine cells and so the most reliable tumor marker in the diagnosis, prognosis, and post-treatment of small-cell lung cancer. NSE being a human brain protein is present in about 0.4–2.2% (>5 ng mL –1 ) of total soluble protein of the brain, and excessive increase in such levels indicates a metastatic disease such as melanoma, seminoma, renal cell carcinoma, carcinoid tumors, Guillain-Barre syndrome, Creutzfeldt-Jakob disease, and so on. , The amount of NSE present in the brain predicts quantifiable measures of brain damage, which lead to strokes, hemorrhage, seizures, etc . Recently, reports have published sufficient data of COVID-19 positive patients showing the elevated level of NSE, signifying the role of NSE as a potential clinical biomarker for COVID-19 because it primarily targets human respiratory and neurological systems. , …”
Section: Introductionmentioning
confidence: 99%
“…Reprinted with permission from Biosens. Bioelectron 2019, 143, 111612, Copyright, 2017, Elsevier 23.…”
mentioning
confidence: 99%